- 2 min ago Ali Fazal And Richa Chadha Pick Ethnic Style For Their Cocktail Bash; See Pictures Here
- 8 min ago National Voluntary Blood Donation Day 2022 Date, History, Significance And Theme
- 1 hr ago Alia Bhatt’s Skincare Routine Is Minimal And Effective: Here’s How All Skin Types Can Make Use Of It
- 6 hrs ago Daily Horoscope, 01 October 2022: Today's Horoscope Predictions For All Zodiac Signs
- Sports Road Safety World Series 2022, FINAL: India Legends face Sri Lanka Legends; all you need to know
- Finance 5 Most Overvalued Multibagger Stocks For October 2022
- News Watch: Massive fire breaks out in Gurugram mall, no injuries reported
- Technology Acer Predator Arc A770 GPU Showcased: Mid-Tier Segment Getting Interesting
- Education Revised KCET Result 2022 is coming today, October 1: know how to check rank and why result is being revised
- Movies Salman Khan's Body Double Sagar Pandey Passes Away; Superstar Pens Emotional Tribute 'Dil Se'
- Automobiles Hero Xtreme 160R Vs Bajaj Pulsar N160 - Which Motorcycle Should You Buy?
- Travel List of The Shortest Rivers In The World
Omicron sub-variant BA.2's offspring BA.2.38 has not led to any increase in hospitalisation or disease severity, and a few deaths reported recently are due to comorbidities, Insacog said in its June 20 bulletin released on Sunday.
In the bulletin, the Indian SARS-CoV-2 Genomics Consortium (Insacog) said many BA.2 cases have been reclassified to BA.2.38 and it seems to be the prevalent sub-lineage in the latest sequencing batches, it said.
"However, so far, this has not led to any increase in hospitalisation or any report of an increase in disease severity. A few deaths that have been reported recently are due to comorbidities. COVID-appropriate behavior is likely to reduce the spread of the infection and hence continues to be recommended," it said.
In its previous bulletin dated June 13, which was also released on Sunday, the Insacog said BA.2 continues to be the dominant lineage in India.
"However, hospitalisation due to the severity of the disease has not been observed that much. INSACOG is closely monitoring the current situation," it said.
In another bulletin dated May 30, the Insacog informed us that till then, five cases of BA.4 and three cases of BA.5 had been reported in India.
The Insacog reports genomic surveillance of SARS-CoV-2 across the country through sequencing of samples from sentinel sites and international passengers arriving in India.
- disorders cureWhat Is ‘Centaurus,’ New Fast-Spreading Covid Variant: Everything You Need To Know
- health75 Years Of Independence, 75 Days Of Free COVID Booster Shots; For Everyone Aged 18-59 From 15 July
- wellnessWhat Are The Health Risks Of Getting COVID The Second Or Third Time? 7 Important Points
- wellnessIllnesses Caused By BA.2.38 Are Mild, Self-Limiting, Says Covid-19 Study
- wellnessGenome Sequencing Tests Show Omicron Dominating In Karnataka: Health Minister
- wellnessHow Does COVID Spread During Short Conversations?
- wellnessLong Covid-19 Risk Less With Omicron Than Delta Variant, UK Study Finds
- wellnessMore Contagious Subvariant Of Omicron Detected In Russia: What You Need To Know
- wellnessOmicron Subvariants BA.4 And BA.5 In India: What You Need To Know
- wellnessHaven't Had Covid-19 Yet? It Could Be More Than Just Luck
- wellnessSouth Africa In New Surge Of COVID-19 From Versions Of Omicron
- wellnessCovid-19 Cases May Rise In June-July, Speeding Up Vaccination Drive Best Way Ahead, Says Maharashtra Minister